Lead Product(s) : Tebipenem Pivoxil
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : University of Washington | GSK | Tres Cantos Open Lab Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Tebipenem Trial in Children With Shigellosis
Details : Tebipenem Pivoxil is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dysentery, Bacillary.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 16, 2021
Lead Product(s) : Tebipenem Pivoxil
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : University of Washington | GSK | Tres Cantos Open Lab Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable